Recent Updates
Recently added Catalysts

Upcoming Catalyst

Drug Pipeline Intelligence

Clinical Trial Results

Inside Trades

Options Data

News Section

Hedge Funds

Ownership Trends

Competitive Position

Astrana Health Inc. Common Stock

$41.2

+1.61 (+4.07%)

0Pipeline Score NOT_PHARMA
Market Cap
1.39 B
EPS
0.46
P/E Ratio
60.58 $
Value Trade
12.39 M
SEC Financials
Q1 2026
  • Dilution Risk

    5%
  • Revenue

    965.10 M

  • Operating CF

    68.06 M


  • Total Assets

    2.36 B

  • Total Liabilities

    1.78 B

  • Equity

    800.27 M

  • D/E Ratio

    12,345

%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Profitable
  • Cash Position

    478.51 M

  • Monthly Burn

    -

  • Runway

    12,345 mo

  • Burn Trend

    Stable
  • SEC Filing

    May 8, 2026
Overview
Volume
737.07 K
52 Week Range
18.08 - 34.80
% held by Insiders
20.23 %
% held by Institutions
60.61 %
Enterprise Value
1.81 B
Total Shares
55.68 M
Short %
5.64 %
Float Shares
42.54 M
Company Description
HQ: 1668 S. GARFIELD AVENUE, ALHAM...
Employees:3,000

locked

Upcoming Catalyst
Catalyst Drug/Treatment Stage Probability of Approval Description Drug Type Therapeutic Area Source
Example Drug Treatment for example condition requiring FDA review
Phase 3
-%
Small Molecule
Oncology
Example Drug Treatment for example condition requiring FDA review
Phase 3
-%
Small Molecule
Oncology
Example Drug Treatment for example condition requiring FDA review
Phase 3
-%
Small Molecule
Oncology
Unlock Upcoming Catalyst data
Drug Pipeline Intelligence
0
Pipeline Score
-
Pipeline Value
Valuation Signal
0
Drugs Scored
rNPV / MCap
Top 2%
Micro Cap
(rank 888 of 905)
Percentile Rank
Unlock Drug Pipeline Intelligence
ASTH Clinical Trial Results & History
Drug Name Indications Phase Date Trial Results Summary Title Source
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01
Unlock Clinical Trial Results data
Inside Trades
TREND
CORPORATE INSIDERS BOUGHT SHARES WORTH 1.8M IN THE LAST 3 MONTHS
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLD
INSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Unlock Inside Trades data
Hedge Funds
TREND
HEDGE FUNDS INCREASED HOLDINGS BY 200.0K SHARES IN THE LAST QUARTER
Shares Held
2040.00B1530.00B1020.00B510.00B0
Q3
2024
Q4
2024
Q1
2025
Q2
2025
HEDGE FUNDS
SOLD
HEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Fund Count
60%
Share Volume
25%
Conviction
15%
HedgeFund Name
( 3 )
% of Portfolio Current MV
-
Shares Owned
-
Activity
Avg Price $0

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K
Unlock Hedge Funds table data
Astrana Health Inc. Common Stock (ASTH) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
ASTH
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
ASTH
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
ASTH
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
Unlock Biotech Analyst Ratings data
ASTH Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
Unlock Price Target Trend
ASTH Institutional Ownership Trends
Current Insider %
5.20%
+0.00%
Current Institutional %
62.40%
+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
ExpirationVolumeOpen InterestImplied Volatility CallsImplied Volatility Puts
CallsPutsPut-Call RatioCallsPutsPut-Call RatioIVOiWaIvVWaIvIVOiWaIvVWaIv
2026-08-210 0.00 0 0 - - - - - -
2026-08-210 0.00 0 0 - - - - - -
2026-08-210 0.00 0 0 - - - - - -
Unlock Option Chain Statistics data
Option Chain
CallsStrikePuts
Last PriceVolumeOpen InterestLast PriceVolumeOpen Interest
No data available
Unlock Option Chain data
Unlock Options Chart data
Open interest
0 600K 1.2M 1.8M Avg OI 1.00 M Open Interest
0 1 2 3 1.1 Put-Call Ratio
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
0 450K 900K 1.4M Avg OV 750.00 K Option Volume
0 1 2 3 0.95 Put-Call Ratio
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-ASTH
May 12, 2026
ASTHGeneral

Astrana Health, Inc. Announces Appointment of Interim National Medical Director

Astrana Health, Inc. has appointed Dr. George Christides as Interim National Medical Director. Dr. Christides brings over 20 years of experience in healthcare leadership, focusing on population health and value-based care. His role will involve leading initiatives across the company's national platform to enhance care management and navigation.

Read more →
-ASTH
May 12, 2026
ASTHGeneral

M e d i c a r e M e d i c a i d C o m m e r c i al O th e r T h i r d P a r t i es F u l l - r i s k P art i a l - r i sk F u l l - r i s k P art i a l - r i sk C a p i t at i o n , n e t R i s k P o o l S et t l e m e n

The article discusses various financial and operational aspects of AstraZeneca's strategies with Medicare and Medicaid. It highlights their risk management approaches, including full-risk and partial-risk models along with incentive management. However, it primarily focuses on cost management and operational metrics, indicating potential challenges. The projected financial outlook for the coming years appears uncertain due to high general and administrative expenses.

Read more →
-ASTH
May 11, 2026
ASTHGeneral

Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care

The Physician Association of California and Astrana Health have announced a collaboration to support independent primary care physicians. This partnership aims to simplify healthcare delivery through an AI-powered platform, enhancing care coordination and reducing administrative burdens. PAC physicians will benefit from improved patient engagement and performance insights, ultimately aiming to improve outcomes for Medicare beneficiaries.

Read more →
-ASTH
May 7, 2026
ASTHConferences/Events

Astrana Health, Inc. Reports First Quarter 2026 Results Company to Host Conference Call on Thursday

Astrana Health, Inc. reported its financial results for the first quarter of 2026, showcasing significant growth across various sectors. The company achieved total revenues of $965.1 million, marking increases of 51% in Care Partners and 155% in Care Delivery compared to the previous year. President Brandon Sim expressed confidence in Astrana's AI-driven healthcare platform, which aims to improve patient outcomes and operational efficiency. The company also provided guidance for future revenue and adjusted EBITDA, reinforcing its positive financial trajectory.

Read more →
-ASTH
Apr 21, 2026
ASTHConferences/Events

Astrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference Call

Astrana Health, Inc. has announced the release of its financial results for Q1 2026, scheduled for May 7, 2026. The company will hold a conference call at 2:30 p.m. PT to discuss these results. A slide presentation will be available on their website, and a recording of the call will be accessible afterward.

Read more →
-ASTH
Apr 10, 2026
ASTHConferences/Events

Astrana Health, Inc. to Participate in Upcoming Investor Conferences

Astrana Health, Inc. announced its participation in several upcoming investor conferences, including the Needham Virtual Healthcare Conference and the Bank of America Global Healthcare Conference. The company's leadership will engage in discussions about their technology-enabled healthcare model. Astrana is committed to improving patient outcomes and provider experiences through its innovative care delivery infrastructure.

Read more →
-ASTH
Mar 30, 2026
ASTHGeneral

PHP Holdings, LLC & Rhode Island Market Condensed Combined and Consolidated Financial Statements (Unaudited) As of

PHP Holdings, LLC and Rhode Island Market released their unaudited combined and consolidated financial statements, showing a net loss of $38,690 for the nine months ended June 30, 2025. The accumulated deficit rose significantly, reaching $1,439,250. Additionally, the total liabilities have increased to $1,569,938, which signals financial challenges for the company. The statements also detail changes in current assets and liabilities, operating revenues, and costs of revenues, providing a snapshot of their financial health.

Read more →
-ASTH
Mar 4, 2026
ASTHConferences/Events

Investor Presentation March 2026 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of the Securi

The investor presentation from Astrana discusses forward-looking statements related to the company's business, financial outlook, and operations. It emphasizes future plans for expansion and integration of acquisitions while acknowledging risks and uncertainties that may affect actual outcomes. Furthermore, the presentation highlights non-GAAP financial measures, indicating efforts to provide investors with insight into the company's operational performance. Notably, Astrana aims to improve healthcare accessibility and quality through their coordinated care delivery model, although they recognize challenges in providing cost-effective solutions.

Read more →
-ASTH
Mar 2, 2026
ASTHConferences/Events

Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results Company to Host Conference Call on Monday

Astrana Health, Inc. has reported significant financial results for the fourth quarter and year-end of 2025, with total revenue growing by 56% to $3,181.8 million. The company also noted an adjusted EBITDA of $205.4 million, reflecting its strong operational performance. However, it acknowledged a material weakness in internal control which has led to a delay in filing its annual Form 10-K. Despite this issue, Astrana remains optimistic about achieving further growth in 2026.

Read more →
-ASTH
Jan 27, 2026
ASTHConferences/Events

Astrana Health, Inc. Schedules 2025 Fourth Quarter and Year-End Financial Results Release and Conference Call

Astrana Health, Inc. has announced the release of its financial results for the fourth quarter and year ending December 31, 2025. The results will be disclosed before the stock market opens on March 2, 2026, followed by a conference call at 5:30 a.m. PT. The call will also be accessible via webcast, with a slide presentation available on the company's website.

Read more →
-ASTH
Jan 12, 2026
ASTHConferences/Events

Investor Presentation January 2026 2 Forward Looking Statements This presentation contains forward -looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of the Secur

Astrana Health provided a detailed outlook for fiscal year 2025, projecting a significant increase in total revenue to between $3,100 million and $3,180 million. Their adjusted EBITDA is expected to rise to between $200 million and $210 million, reflecting strong performance in various business segments. However, the company also acknowledged transaction costs and other legal matters that could pose risks to achieving these financial goals. Furthermore, the forward-looking statements emphasize uncertainties that could impact actual results.

Read more →
-ASTH
Nov 6, 2025
ASTHConferences/Events

Astrana Health, Inc. Reports Third Quarter 2025 Results Company to Host Conference Call on Thursday

Astrana Health, Inc. reported its third quarter 2025 financial results, highlighting solid performance and integration progress with Prospect Health. The company announced strategic partnerships aimed at improving healthcare access and patient outcomes. With total revenues reaching approximately $956 million, Astrana is optimistic about its future, projecting a total revenue guidance of $3.1 billion to $3.18 billion for the year ending December 31, 2025. A conference call to discuss these results will be hosted on November 6, 2025.

Read more →
-ASTH
Aug 7, 2025
ASTHConferences/Events

Astrana Health, Inc. Reports Second Quarter 2025 Results Company to Host Conference Call on Thursday

Astrana Health, Inc. announced its financial results for the second quarter ended June 30, 2025, reporting consolidated revenues of $654.8 million, a 36% increase compared to the previous year. The company's CEO highlighted the strength of their technology-driven model in delivering healthcare. Looking ahead, Astrana provided guidance for Q3 and full-year 2025, indicating expected total revenues between $3.1 billion and $3.3 billion. A conference call is scheduled for August 7, 2025, to discuss these results further.

Read more →
-ASTH
Jul 2, 2025
ASTHGeneral

Astrana Health Announces Closing of Prospect Health Acquisition

Astrana Health has announced the successful closing of its acquisition of Prospect Health, a value-based care delivery network. This acquisition is expected to enhance Astrana's ability to provide patient-centered care and contribute significantly to its revenue and EBITDA. With a network of over 11,000 providers, Prospect Health will enable Astrana to support approximately 600,000 members across different healthcare plans. Additionally, the updated purchase price reflects a cautious approach to capital deployment as the company aims to reduce its net leverage ratio over the next year and a half.

Read more →
-ASTH
Jun 4, 2025
ASTHGeneral

x2022;•••&#x2022

x2022;•••&#x2022

Read more →
-ASTH
May 13, 2025
ASTHGeneral

E 2019 2020 2021 2022 2023 2024 2025E •••••••• 2019 2024 2027E ••••• 2021 2022 2023 2024 2025 Q1 2025E 2025

E 2019 2020 2021 2022 2023 2024 2025E •••••••• 2019 2024 2027E ••••• 2021 2022 2023 2024 2025 Q1 2025E 2025

Read more →
-ASTH
May 8, 2025
ASTHConferences/Events

Astrana Health, Inc. Reports First Quarter 2025 Results Company to Host Conference Call on Thursday

Astrana Health, Inc. released its financial results for the first quarter of 2025, highlighting significant revenue growth in key segments. The company reported total revenues of $620.39 million, a 57% increase compared to the same quarter last year. Despite facing a complex regulatory environment, Astrana remains optimistic about its growth trajectory and continues to invest in technology and AI. The company will host a conference call to discuss these results further and provide guidance for upcoming quarters.

Read more →
-ASTH
Mar 14, 2025
ASTHGeneral

ASTRANA HEALTH, INC. CONSOLIDATED BALANCE SHEETS (IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)

Astrana Health, Inc. has reported significant financial growth in its consolidated balance sheets for the end of 2024, showing total assets of $1.35 billion, up from $933 million in 2023. Stockholders' equity also rose to $716.72 million, reflecting a strong performance. However, the company faces increased non-current liabilities, which have risen by over $171 million, and medical liabilities have more than doubled, creating potential financial pressures.

Read more →
-ASTH
Mar 10, 2025
ASTHConferences/Events

Investor Presentation March 2025 2 Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securitie

The investor presentation discusses AstranaCare's financial results and guidance for 2025, detailing revenue growth and adjusted EBITDA performance. Notably, the company reported a strong growth in total revenues, achieving a 98% increase year-over-year. However, it also recorded a net loss of $7,777 for Q4 2024, alongside rising interest expenses. The emphasis on adjusted EBITDA and stockholders' equity highlights the company's focus on financial health and stability.

Read more →
-ASTH
Feb 27, 2025
ASTHConferences/Events

Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results Company to Host Conference Call on Thursday

Astrana Health, Inc. announced its consolidated financial results for the fourth quarter and year ended December 31, 2024, showcasing strong performance and growth. The company highlighted a 52% increase in total revenues compared to the previous year, emphasizing its commitment to providing high-quality patient-centered care. Additionally, Astrana provided guidance for total revenue for 2025, estimating between $2.5 billion and $2.7 billion, driven by ongoing investments in technology and care integration. The company plans to host a conference call to discuss these results and future strategies.

Read more →
-ASTH
Jan 14, 2025
ASTHGeneral

x2022;••••••• ••••&#x2022

x2022;••••••• •••••

Read more →
-ASTH
Nov 14, 2024
ASTHGeneral

x2022;••••••&#x2022

x2022;•••••••

Read more →
-ASTH
Nov 8, 2024
ASTHGeneral

Astrana Health Announces Definitive Agreement to Acquire Certain Businesses and Assets of Prospect Health System

Astrana Health, Inc. has entered into a definitive agreement to acquire certain businesses and assets of Prospect Health System for $745 million. This deal aims to expand Astrana's provider network and enhance care delivery across four states, supporting approximately 1.7 million members. The acquisition is expected to close in mid-2025, contingent on regulatory approvals. Astrana plans significant investments in Prospect's infrastructure to improve healthcare accessibility and quality in local communities.

Read more →
-ASTH
Nov 7, 2024
ASTHConferences/Events

Astrana Health, Inc. Reports Third Quarter 2024 Results Company to Host Conference Call on Thursday

Astrana Health, Inc. has announced its financial results for the third quarter of 2024, showing significant growth across its business segments compared to the previous year. With total revenues reaching $478.7 million, up 42% year-over-year, the company also adjusted its full-year guidance, reflecting optimistic projections for revenue and adjusted EBITDA. CEO Brandon K. Sim emphasized the effectiveness of Astrana's care model in delivering high-quality healthcare. The company will host a conference call to discuss these results on November 7, 2024.

Read more →
-ASTH
Aug 7, 2024
ASTHConferences/Events

Astrana Health, Inc. Reports Second Quarter 2024 Results Company to Host Conference Call on Wednesday

Astrana Health, Inc. reported strong financial results for the second quarter of 2024, highlighting a 44% revenue growth compared to the same quarter in 2023. The company is expanding into new states such as Arizona and Hawai'i, while integrating recent acquisitions to enhance their healthcare delivery model. Astrana continues to focus on value-based care, successfully managing costs for their one million members. The company has updated its revenue and earnings guidance for 2024 to reflect their continued financial momentum.

Read more →
-ASTH
Jul 25, 2024
ASTHGeneral

Astrana Health Enters Definitive Agreement to Acquire Collaborative Health Systems

Astrana Health, Inc. announced a definitive agreement to acquire Collaborative Health Systems, expanding its care delivery capabilities across 17 states. This acquisition aims to empower both organizations in providing accessible and high-value healthcare services. The transaction is expected to close by the end of the year, subject to regulatory approvals. Astrana plans to leverage its technology platform to enhance the quality of care delivered to patients and support CHS's growth.

Read more →
-ASTH
May 15, 2024
ASTHGeneral

May 2024 Powered by Technology. Built by Doctors. For Patients. 2 Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 199

Astrana Health has reported a notable increase in net income for the three months ending March 31, 2024, rising to $16,862, compared to $12,488 in the same period last year. The company has also achieved consistent profitability, with positive earnings before interest, taxes, depreciation, and amortization (EBITDA) over the last four quarters. Recently, Astrana opened two new de novo clinics in Nevada and completed the acquisition of Advanced Diagnostic Surgical Center, positioning the company for further growth in value-based care services.

Read more →
-ASTH
May 7, 2024
ASTHConferences/Events

Astrana Health, Inc. Reports First Quarter 2024 Results Company to Host Conference Call on Tuesday

Astrana Health, Inc. reported its first quarter results for 2024, showing significant growth in various financial metrics. The company achieved a 20% increase in revenue and a 13% rise in net income compared to the same quarter last year. Additionally, Adjusted EBITDA saw an impressive growth of 42%, fueled by solid membership growth and effective cost management. Astrana remains optimistic about its strategic roadmap and expects continued growth this year, targeting substantial revenue and income for the year ending December 31, 2024.

Read more →
-ASTH
Mar 11, 2024
ASTHGeneral

March 2024 Powered by Technology. Built by Doctors. For Patients. 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of

Astrana Health presented its future vision and performance metrics, emphasizing its tech-driven, provider-centric approach to healthcare. The company reported a significant financial overview, highlighting a revenue of $1.39 billion and an Adjusted EBITDA of $146.6 million. Their model focuses on delivering high-quality, value-based care, reducing hospital admissions and ER visits significantly. The forward-looking statements included in the presentation also stress the integration of acquired companies and emphasize the potential risks that could affect future results.

Read more →
-ASTH
Feb 27, 2024
ASTHConferences/Events

Astrana Health, Inc. Reports Fourth Quarter and Year-End 2023 Results Company to Host Conference Call on Tuesday

Astrana Health, Inc. announced its fourth quarter and year-end 2023 financial results, highlighting a total revenue increase of 20% to $353 million and a net income of $12.4 million. The company is committed to expanding its membership and enhancing provider accountability in value-based care contracts. Additionally, management projects significant revenue growth for 2024, with guidance ranging from $1.65 billion to $1.85 billion. Astrana will host a conference call to discuss these results further.

Read more →
-ASTH
Jan 10, 2024
ASTHGeneral

Apollo Medical Holdings January 2024 Powered by Technology. Built by Doctors. For Patients. Forward - looking Statements This presentation contains forward - looking statements within the meaning of the Private Securitie

Apollo Medical Holdings has outlined its forward-looking strategies and performance metrics for January 2024. The company emphasizes its provider-centric and technology-enabled healthcare model, aimed at improving patient care quality and accessibility. ApolloMed reports significant achievements with a network of over 10,000 providers and a notable adjusted EBITDA of $141 million. The company also highlights its success in reducing hospital admissions and emergency room visits, showcasing the effectiveness of its care delivery model.

Read more →
-ASTH
Nov 30, 2023
ASTHGeneral

Apollo Medical Holdings November 2023 Powered by Technology. Built by Doctors. For Patients. Forward - looking Statements This presentation contains forward - looking statements within the meaning of the Private Securiti

Apollo Medical Holdings shared its November 2023 presentation regarding its business operations and financial performance. The company emphasized its forward-looking statements, which relate to its growth plans, market integration, and financial projections. ApolloMed operates a provider-centric healthcare platform aimed at delivering high-quality care and maintaining strong financial health. The presentation outlines the company's non-GAAP financial measures and its commitment to improving patient care and outcomes through technology-enabled services.

Read more →
-ASTH
Nov 7, 2023
ASTHGeneral

Apollo Medical Holdings, Inc. Reports Third Quarter 2023 Results Company to Host Conference Call on Tuesday

Apollo Medical Holdings, Inc. reported strong financial results for the third quarter of 2023, showing a 10% increase in total revenue and a 34% rise in capitated revenue compared to the previous year. The company achieved an adjusted EBITDA margin of 15% and narrowed its guidance for full-year performance. Additionally, ApolloMed announced plans to acquire assets from Community Family Care Medical Group, further diversifying its membership base. The company expressed confidence in its operational progress and future growth opportunities.

Read more →
-ASTH
Nov 7, 2023
ASTHGeneral

Apollo Medical Holdings, Inc. Announces Definitive Agreement to Acquire Assets of Community Family Care Medical Group IPA, Inc. and Health Plan

Apollo Medical Holdings, Inc. has announced a definitive agreement to acquire the assets of Community Family Care Medical Group IPA, Inc. and its health plan. This acquisition is set to enhance ApolloMed's capabilities in managing Medicaid populations by leveraging CFC's established network and clinical performance. The deal, valued at $202 million, is expected to close in the first quarter of 2024, subject to regulatory approval. CFC has previously served as an ApolloMed client, indicating a strong potential for synergy in the relationship.

Read more →
-ASTH
Sep 13, 2023
ASTHGeneral

Apollo Medical Holdings September 2023 Powered by Technology. Built by Doctors. For Patients. This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of

Apollo Medical Holdings presented a comprehensive overview of its technology-powered healthcare platform in September 2023. The company reported strong financial projections, including a 26% compound annual growth rate in revenue from 2019 to 2023, highlighting its commitment to delivering high-quality, coordinated care. ApolloMed is actively increasing its presence across various markets, serving a diverse patient population through integrated clinical and administrative services. Additionally, the company emphasizes its scalable technology platform aimed at improving healthcare outcomes.

Read more →
-ASTH
Aug 7, 2023
ASTHGeneral

Apollo Medical Holdings, Inc. Reports Second Quarter 2023 Results Company to Host Conference Call on Monday

Apollo Medical Holdings, Inc. reported its financial results for the second quarter of 2023, highlighting a 29% increase in revenue compared to the same period last year. The company experienced a 10% rise in net income and a 44% growth in adjusted EBITDA. These results stem from a focus on membership growth, provider empowerment, and improving patient outcomes across various states. ApolloMed will host a conference call to discuss these results further and provide its guidance for the fiscal year.

Read more →
-ASTH
Jul 31, 2023
ASTHGeneral

Apollo Medical Holdings, Inc. Announces Partnership with IntraCare to Advance Value-Based Care in Texas and Oklahoma

Apollo Medical Holdings, Inc. has announced a partnership with IntraCare to enhance value-based care delivery in Texas and Oklahoma. The collaboration will allow ApolloMed's Accountable Care Organization (ACO) to work with IntraCare's primary care providers under the ACO REACH program, focusing on underserved communities. ApolloMed will also serve as the exclusive care enablement partner for IntraCare, further supporting the expansion of their affiliate network and clinics. Additionally, ApolloMed is lending IntraCare a $25 million senior secured convertible promissory note to aid in its growth efforts.

Read more →
-ASTH
Jul 12, 2023
ASTHGeneral

Apollo Medical Holdings, Inc. Signs Definitive Agreement to Acquire Assets of Texas Independent Providers, Expanding Care Partners Business into Houston

Apollo Medical Holdings, Inc. has signed a definitive agreement to acquire Texas Independent Providers, expanding its Care Partners business into Houston. This acquisition will allow ApolloMed to integrate its value-based care management platform to enhance clinical outcomes for over 4,500 Medicare Advantage patients served by TIP's provider network. Prominent leaders from TIP will join ApolloMed’s team, contributing to its growth strategy in this key geographic market. The transaction is anticipated to close in the third quarter of 2023, funded with ApolloMed’s cash reserves.

Read more →
-ASTH
Jun 7, 2023
ASTHGeneral

Apollo Medical Holdings June 2023 Powered by Technology. Built by Doctors. For Patients. This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, S

Apollo Medical Holdings released a presentation that emphasizes the use of non-GAAP financial measures, such as Adjusted EBITDA, to evaluate its operational performance and aid in resource allocation and forecasting. The company asserts that these measures provide investors with relevant information, improving their understanding of ongoing operations. In its updated methodology, ApolloMed has revised the calculation for Adjusted EBITDA to exclude certain payments that reflect its business more accurately. The presentation suggests ApolloMed is focused on operational efficiency and navigating its financial landscape effectively.

Read more →
-ASTH
May 8, 2023
ASTHGeneral

Document Apollo Medical Holdings, Inc. Reports First Quarter 2023 Results Company to Host Conference Call on Monday

Apollo Medical Holdings, Inc. announced its financial results for Q1 2023, highlighting a total revenue of $337.2 million, representing a 28% increase from the previous year. The net income attributable to the company rose by 3%, though adjusted EBITDA showed a decline. The company has completed the acquisition of For Your Benefit, Inc., allowing it to expand its operational capabilities in California. Management has reiterated its positive outlook for the entire year amid ongoing investments in infrastructure.

Read more →
-ASTH
Feb 24, 2023
ASTHGeneral

Document Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2022 Results Company to Host Conference Call on Friday

Apollo Medical Holdings, Inc. reported its financial results for the fourth quarter and year-end 2022, highlighting a significant revenue increase of 48% year-over-year, totaling $1.14 billion. However, the company faced a net loss of $2.6 million in the fourth quarter and a decrease in earnings per share, marking a challenging end to the year despite overall growth in revenues and EBITDA. Management expressed optimism about future performance, focusing on positioning for long-term growth and improving care delivery models.

Read more →
-ASTH
Dec 15, 2022
ASTHGeneral

Document Apollo Medical Holdings, Inc. Announces Share Repurchase Program

Apollo Medical Holdings, Inc. Announces Share Repurchase Program ALHAMBRA, Calif., December 15, 2022 PRNewswire -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ AMEH), a leading physician-centric, t

Read more →
-ASTH
Nov 4, 2022
ASTHGeneral

Apollo Medical Holdings (NASDAQ: AMEH) Powered by Technology. Built by Doctors. For Patients. Third Quarter 2022 Earnings Call Supplement

1 Apollo Medical Holdings (NASDAQ: AMEH) Powered by Technology. Built by Doctors. For Patients. Third Quarter 2022 Earnings Call Supplement November 4, 2022 Forward - Looking Statements This presentation contains forward - looking statements within the meaning of the Private Sec

Read more →
-ASTH
Nov 4, 2022
ASTHConferences/Events

Document Apollo Medical Holdings, Inc. Reports Third Quarter 2022 Results, Raises Revenue, Net Income and EBITDA Guidance for Full-Year 2022 Company to Host Conference Call on Friday

Apollo Medical Holdings, Inc. Reports Third Quarter 2022 Results, Raises Revenue, Net Income and EBITDA Guidance for Full-Year 2022 Company to Host Conference Call on Friday, Nov. 4, 2022, at 5 30 a.m. PT 8 30 a.m. ET ALHAMBRA, Calif., November 3, 2022 PRNewswire -- Apollo Medi

Read more →
-ASTH
Oct 12, 2022
ASTHConferences/Events

corporateprese Apollo Medical Holdings October 2022 Powered by Technology. Built by Doctors. For Patients. This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Ref

Apollo Medical Holdings October 2022 Powered by Technology. Built by Doctors. For Patients. This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the

Read more →
-ASTH
Oct 5, 2022
ASTHGeneral

Document Apollo Medical Holdings, Inc. Expands into Nevada and Texas with Acquisition of Valley Oaks Medical Group

Apollo Medical Holdings, Inc. Expands into Nevada and Texas with Acquisition of Valley Oaks Medical Group ALHAMBRA, Calif., October 5, 2022 PRNewswire -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDA

Read more →
-ASTH
Sep 26, 2022
ASTHGeneral

Document Apollo Medical Holdings, Inc. Announces Affiliate's Entry into Agreement to Acquire All American Medical Group and For Your Benefit

Apollo Medical Holdings, Inc. Announces Affiliate's Entry into Agreement to Acquire All American Medical Group and For Your Benefit ALHAMBRA, Calif., September 26, 2022 PRNewswire -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated en

Read more →
-ASTH
Aug 4, 2022
ASTHConferences/Events

Document Apollo Medical Holdings, Inc. Reports Second Quarter 2022 Results Company to Host Conference Call Today at 2 p.m. PT 5 p.m.

Apollo Medical Holdings, Inc. Reports Second Quarter 2022 Results Company to Host Conference Call Today at 2 p.m. PT 5 p.m. ET ALHAMBRA, Calif., August 4, 2022 PRNewswire -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities,

Read more →
-ASTH
May 5, 2022
ASTHConferences/Events

Document Apollo Medical Holdings, Inc. Reports First Quarter 2022 Results Company to Host Conference Call Today at 2 p.m. PT 5 p.m.

Apollo Medical Holdings, Inc. Reports First Quarter 2022 Results Company to Host Conference Call Today at 2 p.m. PT 5 p.m. ET ALHAMBRA, Calif., May 5, 2022 PRNewswire -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the

Read more →
-ASTH
Mar 14, 2022
ASTHConferences/Events

Apollo Medical Holdings March 2022 Powered by Technology. Built by Doctors. For Patients. This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995

Apollo Medical Holdings March 2022 Powered by Technology. Built by Doctors. For Patients. This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of the Securities Act and Section 21E of the

Read more →
-ASTH
Feb 24, 2022
ASTHConferences/Events

Document Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2021 Results Company to Host Conference Call Today at 2 p.m. PT 5 p.m.

Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2021 Results Company to Host Conference Call Today at 2 p.m. PT 5 p.m. ET ALHAMBRA, Calif., February 24, 2022 PRNewswire -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affil

Read more →
-ASTH
Jan 27, 2022
ASTHGeneral

Apollo Medical Holdings, Inc. Announces Acquisition of Value-Based Care Technology Platform Orma Health, Welcomes New Chief Analytics Officer and President of Provider Solutions

Apollo Medical Holdings, Inc. Announces Acquisition of Value-Based Care Technology Platform Orma Health, Welcomes New Chief Analytics Officer and President of Provider ALHAMBRA, Calif., January 27, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together

Read more →
-ASTH
Jan 12, 2022
ASTHConferences/Events

Apollo Medical Holdings January 2022 Powered by Technology. Built by Doctors. For Patients. This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 19

Apollo Medical Holdings January 2022 Powered by Technology. Built by Doctors. For Patients. This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of th

Read more →
-ASTH
Dec 21, 2021
ASTHGeneral

Apollo Medical Holdings, Inc. Announces Affiliate's Entry into Agreement to Acquire Jade Health Care Medical Group

Apollo Medical Holdings, Inc. Announces Affiliate's Entry into Agreement to Acquire Jade Health Care Medical Group ALHAMBRA, Calif., December 21, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "C

Read more →
-ASTH
Dec 20, 2021
ASTHGeneral

Apollo Medical Holdings, Inc. Appoints Weili Dai and J. Lorraine Estradas to its Board of Directors

Apollo Medical Holdings, Inc. Appoints Weili Dai and J. Lorraine Estradas to its Board of Directors ALHAMBRA, Calif., December 20, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASD

Read more →
-ASTH
Nov 8, 2021
ASTHGeneral

Apollo Medical Holdings (NASDAQ: AMEH) November 2021 Powered by Technology.

Apollo Medical Holdings (NASDAQ: AMEH) November 2021 Powered by Technology. Built by Doctors. For Patients. Forward - looking statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 2

Read more →
-ASTH
Nov 4, 2021
ASTHConferences/Events

Document Apollo Medical Holdings, Inc. Reports Third Quarter 2021 Results, Raises Full-Year 2021 Guidance Company to Host Conference Call Today at 2 p.m. PT 5 p.m.

Apollo Medical Holdings, Inc. Reports Third Quarter 2021 Results, Raises Full-Year 2021 Guidance Company to Host Conference Call Today at 2 p.m. PT 5 p.m. ET ALHAMBRA, Calif., November 4, 2021 PRNewswire -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsi

Read more →
-ASTH
Nov 3, 2021
ASTHGeneral

Document Apollo Medical Holdings, Inc. Announces Signing of Agreement to Purchase the Remaining 60% of Equity Interests of Diagnostic Medical Group of Southern California Within Three Years

Apollo Medical Holdings, Inc. Announces Signing of Agreement to Purchase the Remaining 60% of Equity Interests of Diagnostic Medical Group of Southern California Within Three Years ALHAMBRA, Calif., November 3, 2021 PRNewswire -- Apollo Medical Holdings, Inc. ("ApolloMed," and t

Read more →
-ASTH
Sep 23, 2021
ASTHGeneral

Document Clinigence Holdings Announces the Completion of a $3 Million Strategic Equity Investment from ApolloMed FT. LAUDERDALE, FL and

Clinigence Holdings Announces the Completion of a $3 Million Strategic Equity Investment from ApolloMed FT. LAUDERDALE, FL and ALHAMBRA, Calif., September 23, 2021 PRNewswire -- Clinigence Holdings, Inc. ("Clinigence") (OTC CLNH), one of the nation's leading technology-enabled,

Read more →
-ASTH
Sep 9, 2021
ASTHConferences/Events

Apollo Medical Holdings (NASDAQ:AMEH) September 2021 Powered by Technology. Built by Doctors. For Patients. Forward - looking statements This presentation contains forward - looking statements within the meaning of the P

Apollo Medical Holdings (NASDAQ:AMEH) September 2021 Powered by Technology. Built by Doctors. For Patients. Forward - looking statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 2

Read more →
-ASTH
Aug 31, 2021
ASTHGeneral

Document Apollo Medical Holdings, Inc. Announces Closing of CAIPA MSO Strategic Investment ALHAMBRA, Calif., and

Apollo Medical Holdings, Inc. Announces Closing of CAIPA MSO Strategic Investment ALHAMBRA, Calif., and NEW YORK, August 31, 2021 PRNewswire -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ AMEH), a

Read more →
-ASTH
Aug 5, 2021
ASTHConferences/Events

Document Apollo Medical Holdings, Inc. Reports Second Quarter 2021 Results, Raises Full-Year 2021 Guidance Company to Host Conference Call Today at 2 p.m. PT 5 p.m.

Apollo Medical Holdings, Inc. Reports Second Quarter 2021 Results, Raises Full-Year 2021 Guidance Company to Host Conference Call Today at 2 p.m. PT 5 p.m. ET ALHAMBRA, Calif., August 5, 2021 PRNewswire -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsid

Read more →
-ASTH
Jun 22, 2021
ASTHConferences/Events

Apollo Medical Holdings (NASDAQ:AMEH) June 2021 Powered by Technology. Built by Doctors. For Patients. Forward - looking statements This presentation contains forward - looking statements within the meaning of the Privat

Apollo Medical Holdings (NASDAQ:AMEH) June 2021 Powered by Technology. Built by Doctors. For Patients. Forward - looking statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of

Read more →
-ASTH
Jun 17, 2021
ASTHGeneral

Apollo Medical Holdings, Inc. Announces Successful Completion of Debt Refinancing, Reducing Annual Interest Rate Spread by 50 Basis Points Current Lenders to Provide a New $400.0 Million Revolving Credit Facility

Medical Holdings, Inc. Announces Successful Completion of Debt Refinancing, Reducing Annual Interest Rate Spread by 50 Basis Points Lenders to Provide a New $400.0 Million Revolving Credit Facility ALHAMBRA, Calif., June 17, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. (

Read more →
-ASTH
Jun 2, 2021
ASTHGeneral

Apollo Medical Holdings, Inc. Announces Purchase of Controlling Interests in Sun Clinical Laboratories

Apollo Medical Holdings, Inc. Announces Purchase of Controlling Interests in Sun Clinical Laboratories ALHAMBRA, Calif., June 2, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ

Read more →
-ASTH
May 18, 2021
ASTHConferences/Events

Apollo Medical Holdings (NASDAQ:AMEH) May 2021 Powered by Technology. Built by Doctors. For Patients. Forward - Looking Statements This presentation contains forward - looking statements within the meaning of the Private

Apollo Medical Holdings (NASDAQ:AMEH) May 2021 Powered by Technology. Built by Doctors. For Patients. Forward - Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of

Read more →
-ASTH
May 5, 2021
ASTHConferences/Events

Apollo Medical Holdings, Inc. Reports First Quarter 2021 Results Company to Host Conference Call Today at 2 p.m. PT/5 p.m.

Apollo Medical Holdings, Inc. Reports First Quarter 2021 Results Company to Host Conference Call Today at 2 p.m. ALHAMBRA, Calif., May 5, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company"

Read more →
-ASTH
Apr 7, 2021
ASTHConferences/Events

A Leader in Integrated Healthcare Management and Delivery Powered by Technology. Built by Doctors. For Patients. April 2021 NASDAQ: AMEH Forward - Looking Statements This presentation contains forward - looking statement

A Leader in Integrated Healthcare Management and Delivery Powered by Technology. Built by Doctors. For Patients. April 2021 NASDAQ: AMEH Forward - Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation R

Read more →
-ASTH
Mar 11, 2021
ASTHConferences/Events

A Leader in Integrated Healthcare Management and Delivery Powered by Technology. Built by Doctors. For Patients. March 2021 NASDAQ: AMEH Forward - Looking Statements This presentation contains forward - looking statement

A Leader in Integrated Healthcare Management and Delivery Powered by Technology. Built by Doctors. For Patients. March 2021 NASDAQ: AMEH Forward - Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation R

Read more →
-ASTH
Mar 10, 2021
ASTHConferences/Events

Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2020 Results, Highlighted by Record Revenue and Net Income Growth for 2020 and Annual Guidance Beat Company to Host Conference Call Today at 2 p.m. PT/5 p

Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2020 Results, Highlighted by Record Revenue and Net Income Growth for 2020 and Annual Guidance Beat Company to Host Conference Call Today at 2 p.m. PT/5 p.m. ET ALHAMBRA, Calif., March 10, 2021 /PRNewswire/ --

Read more →
-ASTH
Feb 16, 2021
ASTHConferences/Events

A Leader in Integrated Healthcare Management and Delivery Powered by Technology. Built by Doctors. For Patients. February 2021 NASDAQ: AMEH Forward - Looking Statements This presentation contains forward - looking statem

A Leader in Integrated Healthcare Management and Delivery Powered by Technology. Built by Doctors. For Patients. February 2021 NASDAQ: AMEH Forward - Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigatio

Read more →
-ASTH
Feb 9, 2021
ASTHGeneral

Document Apollo Medical Holdings, Inc. Promotes Chief Technology Officer Brandon Sim to Chief Operating Officer

Apollo Medical Holdings, Inc. Promotes Chief Technology Officer Brandon Sim to Chief Operating Officer ALHAMBRA, Calif., February 9, 2021 PRNewswire -- Apollo Medical Holdings, Inc. ( ApolloMed, and together with its subsidiaries and affiliated entities, the Company ) (NASDAQ AM

Read more →
-ASTH
Dec 16, 2020
ASTHConferences/Events

A Leader in Integrated Healthcare Management and Delivery Powered by Technology. Built by Doctors. For Patients. December 2020 NASDAQ: AMEH Forward - Looking Statements This presentation contains forward - looking statem

A Leader in Integrated Healthcare Management and Delivery Powered by Technology. Built by Doctors. For Patients. December 2020 NASDAQ: AMEH Forward - Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigatio

Read more →
-ASTH
Nov 12, 2020
ASTHGeneral

A Leader in Integrated Healthcare Management and Delivery Powered by Technology.

A Leader in Integrated Healthcare Management and Delivery Powered by Technology. Built by Doctors. For Patients. Credit Suisse 29 th Annual Virtual Healthcare Conference November 12, 2020 NASDAQ: AMEH Forward - Looking Statements This presentation contains forward - looking stat

Read more →
-ASTH
Nov 4, 2020
ASTHGeneral

Document Apollo Medical Holdings, Inc. Reports Third Quarter 2020 Results, Raises Full-Year 2020 Guidance

Apollo Medical Holdings, Inc. Reports Third Quarter 2020 Results, Raises Full-Year 2020 Guidance ALHAMBRA, Calif., November 4, 2020 PRNewswire -- Apollo Medical Holdings, Inc. ( ApolloMed, and together with its subsidiaries and affiliated entities, the Company ) (NASDAQ AMEH), a

Read more →
-ASTH
Sep 10, 2020
ASTHConferences/Events

investorpresen Investor Presentation September 2020 Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A

Investor Presentation September 2020 Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-lookin

Read more →
-ASTH
Aug 7, 2020
ASTHGeneral

Apollo Medical Holdings, Inc.

Apollo Medical Holdings, Inc. Reports Second Quarter Ended June 30, 2020 Results ALHAMBRA, Calif., August 7, 2020 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), an integrated

Read more →
-ASTH
Jan 14, 2020
ASTHConferences/Events

Investor Presentation January 2020 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of the Secu

Investor Presentation January 2020 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of the Securities Act and Section 21E of the Exchange Act, such as sta

Read more →
-ASTH
Nov 8, 2019
ASTHGeneral

C O R R E C T I O N -- Apollo Medical Holdings, Inc./ In the news release, Apollo Medical Holdings, Inc. Reports: 3Q19 Total Revenues of $156.1 Million, Up 20.0% Over 2Q19; 3Q19 Adjusted EBITDA of $22.8 Million, Up 55.6%

/C O R R E C T I O N -- Apollo Medical Holdings, Inc./ In the news release, Apollo Medical Holdings, Inc. Reports: 3Q19 Total Revenues of $156.1 Million, Up 20.0% Over 2Q19; 3Q19 Adjusted EBITDA of $22.8 Million, Up 55.6% Over 3Q18; Capitated Membership of Over One Million Manag

Read more →
-ASTH
Oct 3, 2019
ASTHConferences/Events

Cantor Fitzgerald Global Healthcare Conference October 2019 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995

Cantor Fitzgerald Global Healthcare Conference October 2019 2 Forward Looking Statements This presentation contains forward - looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 , Section 27A of the Securities Act and Section 21E of the

Read more →
-ASTH
Oct 2, 2019
ASTHGeneral

APOLLO MEDICAL HOLDINGS ADDS APPROXIMATELY 145,000 MEMBERS BY ENTERING INTO NEW MANAGEMENT SERVICES AGREEMENT Alhambra, CA - (PR Newswire)

APOLLO MEDICAL HOLDINGS ADDS APPROXIMATELY 145,000 MEMBERS BY ENTERING INTO NEW MANAGEMENT SERVICES AGREEMENT Alhambra, CA - (PR Newswire) - October 2, 2019 - Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health managemen

Read more →
-ASTH
Sep 30, 2019
ASTHGeneral

APOLLO MEDICAL HOLDINGS ANNOUNCES THE APPOINTMENT OF MATTHEW MAZDYASNI TO ITS BOARD OF DIRECTORS AND APPOINTMENT OF NEW INTERIM CHIEF TECHNOLOGY OFFICER Alhambra, CA - (PR Newswire)

APOLLO MEDICAL HOLDINGS ANNOUNCES THE APPOINTMENT OF MATTHEW MAZDYASNI TO ITS BOARD OF DIRECTORS AND APPOINTMENT OF NEW INTERIM CHIEF TECHNOLOGY OFFICER Alhambra, CA - (PR Newswire) - September 30, 2019 - Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ:

Read more →
-ASTH
Sep 11, 2019
ASTHGeneral

APOLLO MEDICAL HOLDINGS ANNOUNCES THE CLOSING OF ITS INAUGURAL $290 MILLION SYNDICATED CREDIT FACILITY AND SERIES OF TRANSACTIONS WITH INDEPENDENT PRACTICE ASSOCIATION AND PROFESSIONAL MEDICAL CORPORATION Alhambra, CA -

APOLLO MEDICAL HOLDINGS ANNOUNCES THE CLOSING OF ITS INAUGURAL $290 MILLION SYNDICATED CREDIT FACILITY TRANSACTIONS WITH INDEPENDENT PRACTICE ASSOCIATION AND PROFESSIONAL MEDICAL CORPORATION Alhambra, CA - (PR Newswire) - September 11, 2019 - Apollo Medical Holdings, Inc. ("Ap

Read more →
-ASTH
Sep 5, 2019
ASTHGeneral

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as ame

APOLLO MEDICAL HOLDINGS ANNOUNCES ACQUISITION OF ACCOUNTABLE HEALTH CARE IPA Alhambra, CA - (PR Newswire) - September 5, 2019 - Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, today announced that i

Read more →
-ASTH
Aug 9, 2019
ASTHGeneral

APOLLO MEDICAL HOLDINGS REPORTS REVENUE OF $130.0 MILLION FOR THE SECOND QUARTER OF 2019 Alhambra, CA- (PR Newswire)

APOLLO MEDICAL HOLDINGS REPORTS REVENUE OF $130.0 MILLION FOR THE SECOND QUARTER OF 2019 Alhambra, CA- (PR Newswire) - August 9, 2019 - Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, announced its

Read more →
-ASTH
Jun 4, 2019
ASTHGeneral

APOLLO MEDICAL HOLDINGS ANNOUNCES ACQUISITION OF ALPHA CARE MEDICAL GROUP Alhambra, CA - (PR Newswire)

APOLLO MEDICAL HOLDINGS ANNOUNCES ACQUISITION OF ALPHA CARE MEDICAL GROUP Alhambra, CA - (PR Newswire) - June 4, 2019 - Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, today announced that Allied

Read more →
-ASTH
May 13, 2019
ASTHGeneral

APOLLO MEDICAL HOLDINGS ANNOUNCES SIGNING OF AGREEMENTS WITH INDEPENDENT PRACTICE ASSOCIATION AND PROFESSIONAL MEDICAL CORPORATION AND REPORTS RESULTS OF THE FIRST QUARTER OF 2019 Effect of transactions is expected to mo

APOLLO MEDICAL HOLDINGS ANNOUNCES SIGNING OF AGREEMENTS WITH INDEPENDENT PRACTICE ASSOCIATION AND PROFESSIONAL MEDICAL CORPORATION AND REPORTS RESULTS OF THE FIRST QUARTER Effect of transactions is expected to more fully integrate the financial results of Allied Physicians

Read more →
-ASTH
Mar 18, 2019
ASTHGeneral

APOLLO MEDICAL HOLDINGS REPORTS 46% REVENUE INCREASE FOR 2018 Alhambra, CA and Glendale, CA - (PR Newswire)

APOLLO MEDICAL HOLDINGS REPORTS 46% REVENUE INCREASE FOR 2018 Alhambra, CA and Glendale, CA - (PR Newswire) - March 18, 2019 - Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management company, today announced its c

Read more →
-ASTH
Jan 17, 2019
ASTHGeneral

APOLLO MEDICAL HOLDINGS ANNOUNCES THE APPOINTMENT OF LINDA MARSH AND JOHN CHIANG TO ITS BOARD OF DIRECTORS Alhambra, CA and Glendale, CA (PR Newswire)

APOLLO MEDICAL HOLDINGS ANNOUNCES THE APPOINTMENT OF LINDA MARSH AND JOHN CHIANG TO ITS BOARD OF DIRECTORS Alhambra, CA and Glendale, CA (PR Newswire) January 17, 2018 Apollo Medical Holdings, Inc. ( ApolloMed or the Company ) (NASDAQ: AMEH), an integrated population health man

Read more →
-ASTH
Dec 21, 2018
ASTHGeneral

APOLLO MEDICAL HOLDINGS ANNOUNCES THAT APA ACO GENERATED $12.96 MILLION IN GROSS SAVINGS IN 2017 AND ACHIEVED $5.90 MILLION IN SHARED SAVINGS FROM THE CENTERS FOR MEDICARE AND MEDICAID SERVICES AS A RESULT Alhambra, CA a

APOLLO MEDICAL HOLDINGS ANNOUNCES THAT APA ACO GENERATED $12.96 MILLION IN GROSS SAVINGS IN 2017 AND ACHIEVED $5.90 MILLION IN SHARED SAVINGS FROM THE CENTERS FOR MEDICARE AND MEDICAID SERVICES AS A RESULT Alhambra, CA and Glendale, CA (PR Newswire) December 21, 2018 Apollo Medi

Read more →
-ASTH
Nov 14, 2018
ASTHGeneral

APOLLO MEDICAL HOLDINGS REPORTS 72% REVENUE INCREASE YEAR OVER YEAR FOR THE THIRD QUARTER OF 2018 Alhambra, CA and Glendale, CA - (PR Newswire)

APOLLO MEDICAL HOLDINGS REPORTS 72% REVENUE INCREASE YEAR OVER YEAR FOR THE THIRD QUARTER OF 2018 Alhambra, CA and Glendale, CA - (PR Newswire) - November 14, 2018 - Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (NASDAQ: AMEH), an integrated population health ma

Read more →
-ASTH
Aug 14, 2018
ASTHGeneral

APOLLO MEDICAL HOLDINGS REPORTS 51% REVENUE INCREASE YEAR OVER YEAR FOR THE 2ND QUARTER OF 2018 Alhambra, CA and Glendale, CA - (PR Newswire)

APOLLO MEDICAL HOLDINGS REPORTS 51% REVENUE INCREASE YEAR OVER YEAR FOR THE 2ND QUARTER OF 2018 Alhambra, CA and Glendale, CA - (PR Newswire) - August 14, 2018 - Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (NASDAQ: AMEH), an integrated population health manag

Read more →
-ASTH
Jun 26, 2018
ASTHGeneral

APOLLO MEDICAL HOLDINGS ANNOUNCES THE APPOINTMENT OF ERNEST A. BATES, M.D. AND J. MARIO MOLINA, M.D. TO ITS BOARD OF DIRECTORS Alhambra, CA and Glendale, CA - (PR Newswire)

MEDICAL HOLDINGS ANNOUNCES THE APPOINTMENT OF A. BATES, M.D. AND J. MARIO MOLINA, M.D. CA and Glendale, CA - (PR Newswire) - June 26, 2018 - Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (NASDAQ: AMEH), an integrated population health management company, today a

Read more →
-ASTH
Jun 6, 2018
ASTHGeneral

APOLLO MEDICAL HOLDINGS ANNOUNCES APPOINTMENT OF NEW CHIEF FINANCIAL OFFICER Alhambra, CA and Glendale, CA - (PR Newswire)

APOLLO MEDICAL HOLDINGS ANNOUNCES APPOINTMENT OF NEW CHIEF FINANCIAL OFFICER CA and Glendale, CA - (PR Newswire) - June 6, 2018 - Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (NASDAQ: AMEH), an integrated population health management company, is pleased to anno

Read more →
-ASTH
May 15, 2018
ASTHGeneral

APOLLO MEDICAL HOLDINGS REPORTS 46% REVENUE GROWTH YEAR OVER YEAR FOR THE 1st QUARTER OF 2018 Alhambra, CA and Glendale, CA - (PR Newswire)

APOLLO MEDICAL HOLDINGS REPORTS YEAR OVER YEAR FOR THE 1st QUARTER OF 2018 Alhambra, CA and Glendale, CA - (PR Newswire) - May 15, 2018 - Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (NASDAQ: AMEH), an integrated population health management company, today ann

Read more →
-ASTH
Feb 13, 2017
ASTHGeneral

PROMISSORY NOTE $5,000,000

This PROMISSORY NOTE (this "Note") is dated as of the date written above and is made by APOLLO MEDICAL HOLDINGS, INC., a Delaware corporation ("AMH"), in favor and for the benefit of NETWORK MEDICAL MANAGEMENT, INC., a California corporation ("NMM"), with reference to the foll

Read more →
-ASTH
Jan 19, 2017
ASTHGeneral

ApolloMED announces that apa ACo, Inc. has been chosen as a next generation accountable care organization GLENDALE, CA (PR Newswire)

announces that apa ACo, Inc. has been chosen as a generation accountable care organization CA (PR Newswire) - January 19, 2017 Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (OTC: AMEH), an integrated population health management company, today announced that one

Read more →
-ASTH
Dec 21, 2016
ASTHGeneral

EXECUTION AGREEMENT AND PLAN OF MERGER by and among APOLLO MEDICAL HOLDINGS, INC., APOLLO ACQUISITION CORP., NETWORK MEDICAL MANAGEMENT, INC., and THE SHAREHOLDERS' REPRESENTATIVE NAMED HEREIN Dated as of

AGREEMENT AND PLAN OF MERGER APOLLO MEDICAL HOLDINGS, INC., APOLLO ACQUISITION CORP., NETWORK MEDICAL MANAGEMENT, THE SHAREHOLDERS' REPRESENTATIVE Dated as of December 21, 2016 Page ARTICLE I THE MERGER 2 1.1 The Merger 2 1.2 Closing 2 1.3 Effective Time 3 1.4 Effects of t

Read more →
-ASTH
Dec 20, 2016
ASTHGeneral

EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this " Agreement ") is made and entered into as of

EMPLOYMENT AGREEMENT AGREEMENT (this "Agreement") is made and entered into as of December 20, 2016, by and between Apollo Medical Management, Inc., a California corporation (the "Employer"), and Gary Augusta (the "Employee" and together with the Employer referred to as the "Pa

Read more →
-ASTH
Jul 25, 2016
ASTHGeneral

Apollo MEDICAL HOLDINGS APPOINTS MIHIR SHAH AS Chief financial officer GLENDALE, CA (PR Newswire)

Apollo MEDICAL HOLDINGS APPOINTS MIHIR SHAH AS Chief financial officer CA (PR Newswire) - July 25, 2016 Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (OTC: AMEH), an integrated population health management company, today announced the appointment of Mihir Shah,

Read more →
-ASTH
Mar 31, 2016
ASTHGeneral

APOLLO MEDICAL HOLDINGS RECEIVES $5 MILLION EQUITY INVESTMENT FROM NETWORK MEDICAL MANAGEMENT 2 nd STRATEGIC INVESTMENT FURTHERS PARTNERSHIP INITIATIVES GLENDALE, CA (PR Newswire)

APOLLO MEDICAL HOLDINGS RECEIVES $5 MILLION EQUITY INVESTMENT FROM NETWORK MEDICAL MANAGEMENT 2nd STRATEGIC INVESTMENT FURTHERS PARTNERSHIP INITIATIVES CA (PR Newswire) - March 31, 2016 Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (OTC: AMEH), an integrated p

Read more →
-ASTH
Jan 19, 2016
ASTHGeneral

Medical Holdings Announces the Appointment of

Medical Holdings Announces the Appointment of fawcett to its Board of Directors CA (PR Newswire) - January 13, 2016 Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (AMEH), an integrated population health management company, today announced the appointment of Mark

Read more →
-ASTH
Nov 19, 2015
ASTHGeneral

The following unaudited pro forma condensed consolidated balance sheet shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subj

The following unaudited pro forma condensed consolidated balance sheet shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall it be d

Read more →
-ASTH
Oct 19, 2015
ASTHGeneral

APOLLO MEDICAL HOLDINGS ANNOUNCES THE COMPLETION OF A $10 MILLION STRATEGIC EQUITY INVESTMENT Glendale, CA - (PR Newswire) - OCTOBER 15, 2015 - Apollo Medical Holdings, Inc. ( ApolloMed or "the Company") (AMEH), an integ

APOLLO MEDICAL HOLDINGS ANNOUNCES THE COMPLETION OF A $10 MILLION STRATEGIC EQUITY INVESTMENT Glendale, CA - (PR Newswire) - OCTOBER 15, 2015 - Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (AMEH), an integrated population health management company, today annou

Read more →
-ASTH
Sep 25, 2015
ASTHGeneral

APOLLO MEDICAL HOLDINGS ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS AND CFO POSITION Glendale, CA - (PR Newswire) - SEPTEMBER 24, 2015 - Apollo Medical Holdings, Inc. ( ApolloMed or "the Company") (AMEH), an integrated p

APOLLO MEDICAL HOLDINGS ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS AND CFO POSITION Glendale, CA - (PR Newswire) - SEPTEMBER 24, 2015 - Apollo Medical Holdings, Inc. ("ApolloMed" or "the Company") (AMEH), an integrated population health management company, today announced t

Read more →
-ASTH
Jun 14, 2013
ASTHGeneral

Apollo Medical Holdings Reports Strong Fiscal 2014 First Quarter Results Net Revenues Climb 50% to $2.45 Million Compared to $1.63 Million for Same Three Month Reporting Period in Prior Fiscal Year Glendale, CA - (PR New

Medical Holdings Reports Strong Fiscal 2014 First Quarter Results Revenues Climb 50% to $2.45 Million Compared to $1.63 Million for Three Month Reporting Period in Prior Fiscal Year Glendale, CA - (PR Newswire) - June 14, 2013 - Apollo Medical Holdings, Inc. ("ApolloMed") (OT

Read more →
-ASTH
Jun 5, 2013
ASTHGeneral

apollo medical HOLDINGS ANNOUNCES Launch OF NEW OPERATING UNIT: MAVERICK MEDICAL GROUP GLENDALE, CA - (PR Newswire)

medical HOLDINGS ANNOUNCES Launch OF OPERATING UNIT: MAVERICK MEDICAL GROUP GLENDALE, CA - (PR Newswire) - June 5, 2013 - Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB:AMEH), an integrated physician-driven healthcare delivery company that puts Patients First,' today anno

Read more →
-ASTH
May 22, 2013
ASTHGeneral

Apollo Medical Holdings Announces the Appointment of David G. Schmidt to its Board of Directors GLENDALE, CA (PR Newswire)

Medical Holdings Announces the Appointment of G. Schmidt to its Board of Directors CA (PR Newswire) - May 22, 2013 Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB:AMEH), an integrated physician-driven healthcare delivery company that puts Patients First,' today announced th

Read more →
-ASTH
May 3, 2013
ASTHGeneral

Apollo Medical Holdings Announces Record Fiscal Year-End Results Glendale, CA - (PR Newswire)

Apollo Medical Holdings Announces Record Fiscal Year-End Results Glendale, CA - (PR Newswire) - May 3, 2013 - Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), an integrated physician-driven healthcare delivery company that puts Patients First,' today announced its

Read more →
-ASTH
Oct 17, 2012
ASTHGeneral

Apollo Medical Holdings, Inc. Announces Appointment Of Mark A. Meyers To Its Board of Directors Company Also Names Mr. Meyers As Its Chief Strategy Officer

Apollo Medical Holdings, Inc. Announces Appointment Of Mark A. Meyers To Its Board of Directors Company Also Names Mr. Meyers As Its Chief GLENDALE, Calif., Oct. 17, 2012 /PRNewswire via COMTEX/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB-AMEH), a leading provider o

Read more →
-ASTH
Mar 7, 2012
ASTHGeneral

OF APOLLO MEDICAL HOLDINGS, INC. DATED MARCH 7, 2012.

Apollo Medical Holdings, Inc. Appoints Gary Augusta to GLENDALE, Calif., March 7, 2012 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-AMEH), a leading provider of hospitalist, critical care and multi-disciplinary care management services to the healthcare com

Read more →
-ASTH
Feb 16, 2011
ASTHGeneral

AMEH.OB: OTCBB

Apollo Medical Holdings, Inc. Announces Acquisition of Aligned Healthcare, Inc. Glendale, California.- Apollo Medical Holdings, Inc. ("Apollo") (OTCBB:AMEH - News), a leading provider of hospitalist services to the healthcare community, today announced that it has acquired Align

Read more →
-ASTH
Mar 4, 2010
ASTHGeneral

APOLLO MEDICAL HOLDINGS, INC. 2010 EQUITY INCENTIVE PLAN 1. PURPOSES OF THE PLAN The purposes of the 2010 Equity Incentive Plan (the " Plan ") of Apollo Medical Holdings, Inc., a Delaware corporation (the " Company "), a

MEDICAL HOLDINGS, INC. EQUITY INCENTIVE PLAN purposes of the 2010 Equity Incentive Plan (the "Plan") of Apollo Medical Holdings, Inc., a Delaware corporation (the "Company"), are selected employees, directors, consultants and advisers to improve operations and increase the p

Read more →
-ASTH
Oct 16, 2009
ASTHGeneral

Apollo Medical Holdings, Inc. Announces Completion of $1.25 Million Private Placement of Convertible Notes Glendale, California

Medical Holdings, Inc. Announces Completion of $1.25 Million Private Placement of Convertible Notes Glendale, California, October 16, 2009 - Apollo Medical Holdings, Inc. (OTC-BB:AMEH), a leading provider of management services to medical groups that provide comprehensive hos

Read more →
-ASTH
Sep 11, 2008
ASTHGeneral

APOLLO MEDICAL HOLDINGS APPOINTS NOEL DEWINTER CHIEF FINANCIAL OFFICER Glendale, California

MEDICAL HOLDINGS APPOINTS NOEL DEWINTER CHIEF FINANCIAL California, September 11, 2008 - Apollo Medical Holdings, Inc. (OTC-BB:AMEH), a leading provider of management services to medical groups provide comprehensive hospital-based medical services, today announced the appoint

Read more →
-ASTH
Jun 19, 2008
ASTHGeneral

Report of Independent Registered Public Accounting Firm Board of Directors and Stockholders of Apollo Medical Management, Inc (A Development Stage Company) We have audited the accompanying balance sheet of Apollo Medical

of Independent Registered Public Accounting Firm Directors and Stockholders of Medical Management, Inc Development Stage Company) have audited the accompanying balance sheet of Apollo Medical Management, Inc development stage company) as of January 31, 2008 and the related s

Read more →
Competitive Position
How ASTH ranks across every disease it competes in
Competitive Position is a premium feature
See how ASTH ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial